ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #5,030Hybrid

Journal of Asthma and Allergy

Abbreviation (ISO):J ASTHMA ALLERGY
•
Identifier (ISSN):1178-6965(Print)
•
Publisher:Dove Medical Press
Clarivate IF (2026)
3.3↑ +0.3
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2020–2026)

Clarivate IF trend for Journal of Asthma and Allergy

WoS Q2
23563.7320204.2620213.0320223.220233.72024320253.32026
Annual Impact Factor Metric
Current (2026):3.3
Scopus SJR & RankScopus Q1
0.983
#5,030

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
51

51 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
139articles/year
99.19% Gold OA•80.14% Original Research

Aims & Scope

An international, peer-reviewed journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physiology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies. Although the main focus of the journal will be to publish research and clinical results in humans, preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies.

Topics Covered (Recognized by AI)
Medicine92.2%Biology91.8%Immunology89.3%Internal medicine86.8%Asthma68%Pathology52.6%Psychology40.9%Genetics38.4%Surgery36.2%Psychiatry29.7%Chemistry28.1%Mathematics27.1%Allergy26.4%Pediatrics25.2%Biochemistry24.4%Anesthesia24.1%Statistics23.5%Physics23.3%Intensive care medicine20.2%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ALLERGY

Q2
Rank17/40
IndexSCIE
JCRSCIE2026

IMMUNOLOGY

Q3
Rank99/183
IndexSCIE
JCRSCIE2026

RESPIRATORY SYSTEM

Q2
Rank39/107
IndexSCIE
JCISCIE2026

ALLERGY

Q2
Rank16/40
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q2
Rank82/183
IndexSCIE
JCISCIE2026

RESPIRATORY SYSTEM

Q2
Rank42/107
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.3
Articles / Year105
Total Citations12
2025
IF3
Articles / Year148
Total Citations358
2024
IF3.7
Articles / Year117
Total Citations621
2023
IF3.2
Articles / Year125
Total Citations1,217
2022
IF3.027
Articles / Year151
Total Citations2,437

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,030Scopus Q1SCImago Profile
Scopus Coverage:2008-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
0.983

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.32

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,285 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,413
3-Year Documents384
Citable Documents365

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pulmonary and Respiratory MedicineQ1
Immunology and AllergyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区ALLERGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Asthma and Allergy (abbr: J ASTHMA ALLERGY, ISSN: 1178-6965) is a peer-reviewed international scholarly journal in the field of Medicine, published by Dove Medical Press in New Zealand. The periodical holds a Journal Impact Factor (JIF) of 3.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.983 (Q1), an H-index of 51.

The journal enforces rigorous peer evaluation with an annual output of approximately 139 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,285 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Dove Medical Press
Publication Language
English
Frequency
Periodic
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b7683a62-35af-42bd-8568-6c3750872233
Database Updated: 2026-10-01